section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLa)

I

Polymyxin B sulfate

(Mfr: XE)(Conc: 1250 units/mLa)

Remarks:

Results of subvisual tests indicate high turbidity

Ref:

3662